ArticleInternational urology and nephrology2026
Development and validation of a multidimensional machine learning model for predicting delayed graft function in deceased donor kidney transplantation.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
purposeDelayed graft function (DGF) remains a significant complication following deceased donor kidney transplantation. This study aimed to develop and validate a multidimensional machine learning model for predicting DGF by integrating clinical data, machine perfusion parameters, donor scores, and histopathological scores.
methodsA retrospective analysis was conducted on 961 deceased donor kidney transplant recipients from January 2019 to December 2021. The dataset was stratified by the target variable and randomly divided into training (80%) and independent testing (20%) cohorts. Fifteen data combinations across four dimensions were evaluated using six machine learning algorithms. Model performance was assessed using AUC, calibration curves, and decision curve analysis. SHAP analysis was employed for feature interpretation.
resultsThe optimal model combining clinical supplementary data with donor scores and histopathological scores using LightGBM achieved an AUC of 0.895 (95% CI 0.806-0.985) in the testing cohort, with accuracy of 89.1%, sensitivity of 59.1%, and specificity of 93.0%. Clinical data served as the foundational predictive dimension (AUC = 0.874), while histopathological scores provided significant incremental value (ΔAUC = 0.016). Among the top five ranked combinations, four included histopathological scores. Gain-based feature importance identified donor score, renal tubular necrosis, and total pathological score as the leading predictors, with pathological indicators occupying four of the top five positions; SHAP analysis further revealed blood urea nitrogen and donor score as the most influential individual features, with renal tubular necrosis being the top-ranked histopathological predictor.
conclusionThis multidimensional machine learning model demonstrates excellent predictive performance for DGF. The "scenario-model-threshold" clinical decision framework provides a practical tool for guiding donor kidney assessment and immunosuppressive therapy decisions in diverse clinical contexts.
Indexed as
Identifiers
42635724What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.